These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19583964)

  • 1. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
    Tárrega C; Pulido R
    Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.
    Muñoz JJ; Tárrega C; Blanco-Aparicio C; Pulido R
    Biochem J; 2003 May; 372(Pt 1):193-201. PubMed ID: 12583813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
    González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
    Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.
    Tárrega C; Ríos P; Cejudo-Marín R; Blanco-Aparicio C; van den Berk L; Schepens J; Hendriks W; Tabernero L; Pulido R
    J Biol Chem; 2005 Nov; 280(45):37885-94. PubMed ID: 16148006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.
    Owens DM; Keyse SM
    Oncogene; 2007 May; 26(22):3203-13. PubMed ID: 17496916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
    Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
    J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
    Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
    J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease.
    Pulido R; Hooft van Huijsduijnen R
    FEBS J; 2008 Mar; 275(5):848-66. PubMed ID: 18298792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of MAP kinases in bacteria.
    Heise CJ; Cobb MH
    Methods; 2006 Nov; 40(3):209-12. PubMed ID: 16908184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
    Park JE; Park BC; Song M; Park SG; Lee DH; Park SY; Kim JH; Cho S
    Biochem Biophys Res Commun; 2009 Oct; 387(4):795-9. PubMed ID: 19646420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell adhesion by tyrosine kinases and phosphatases inhibitors.
    Stefănescu M; Matache C; Onu A; Szegli G
    Roum Arch Microbiol Immunol; 1997; 56(1-2):3-15. PubMed ID: 9558971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
    Zhou T; Sun L; Humphreys J; Goldsmith EJ
    Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.
    Zhang YY; Mei ZQ; Wu JW; Wang ZX
    J Biol Chem; 2008 Sep; 283(39):26591-601. PubMed ID: 18669639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification and functional characterization of a Drosophila dual-specificity phosphatase DMKP-4 which is involved in PGN-induced activation of the JNK pathway.
    Sun L; Yu MC; Kong L; Zhuang ZH; Hu JH; Ge BX
    Cell Signal; 2008 Jul; 20(7):1329-37. PubMed ID: 18456458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of kinase-interaction-motif protein tyrosine phosphatases with the mitogen-activated protein kinase ERK2.
    Francis DM; Koveal D; Tortajada A; Page R; Peti W
    PLoS One; 2014; 9(3):e91934. PubMed ID: 24637728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
    Fukada M; Kawachi H; Fujikawa A; Noda M
    Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeast.
    Friedmann Y; Shriki A; Bennett ER; Golos S; Diskin R; Marbach I; Bengal E; Engelberg D
    Mol Pharmacol; 2006 Oct; 70(4):1395-405. PubMed ID: 16847144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.